IPO Voluntis

Voluntis lists on Euronext

Pierre Leurent, CEO of Voluntis, open the trading day at Euronext Paris

Voluntis specializes in the development of medical software solutions enabling patients to treat their own illnesses while in remote contact with their healthcare team. The company markets Insulia and Diabeo for diabetes, and eCO and Zemy for oncology. These digital companion products make it possible to guide and help patients to administer treatment, support them throughout the process and facilitate monitoring by their doctors.